-+ 0.00%
-+ 0.00%
-+ 0.00%

Barclays Maintains Overweight on Omada Health, Raises Price Target to $29

Benzinga·11/07/2025 15:43:58
Listen to the news
Barclays analyst Saket Kalia maintains Omada Health (NASDAQ:OMDA) with a Overweight and raises the price target from $28 to $29.